Corgic

Quick links to important sections

Corgic

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Corgic

Defining Corgic: Identity and Pharmacological Class

Corgic is a trademarked medicinal product containing Acetaminophen as its single active ingredient, which is internationally recognized by the nonproprietary name Paracetamol. This synthetic compound is classified pharmacologically as a non-opioid analgesic and an antipyretic agent, designations that define its core function to address pain and fever.

Corgic is typically positioned as an over-the-counter (OTC) analgesic. Its active formulation, derived from the para-aminophenol chemical group, works fundamentally differently from Nonsteroidal Anti-inflammatory Drugs (NSAIDs), a distinction based on its minimal anti-inflammatory activity.


Pharmaceutical Forms and General Purpose

The active ingredient is consistently formulated as a single-ingredient product, enabling its administration through various pharmaceutical preparations to suit different patient needs. These forms include the standard oral tablet and capsule, as well as specialized formats such as oral solution and suspension suitable for pediatric patients.

For alternate routes, the medicine is also prepared as a suppository for rectal use and a sterile solution designated for intravenous (IV) infusion in acute clinical settings. The general therapeutic purpose of Corgic is focused on symptomatic relief, specifically the management of mild to moderate pain and the reduction of fever.

Regulatory References

  1. NIH Acetaminophen (Paracetamol) entry

What side effects are possible with Corgic?

Adverse Reaction Scope

The most critical safety concern documented in regulatory labeling across major health authorities (e.g., FDA, EMA) is the risk of hepatotoxicity (liver damage), which may progress to acute liver failure. This risk is primarily associated with intake that exceeds the cumulative recommended dose over a 24-hour period.

The official adverse reaction categories include effects on the Hepatobiliary Disorders (liver function), Blood and Lymphatic System Disorders, and the Immune System.

Serious Adverse Reactions

Specific rare but serious adverse reactions are documented, including:

  • Acute Liver Failure, a potentially fatal event strictly linked to dose dependency.
  • Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), which are classified as Very Rare in official safety documents.
  • Hematological Disturbances (e.g., Agranulocytosis, Thrombocytopenia) and Anaphylactic Shock, which are generally classified as Rare systemic effects.

Population-Specific Safety Constraints

Regulatory documents impose specific safety limitations for certain populations: Corgic is contraindicated in individuals with known severe hepatic impairment or severe active liver disease. Caution is specified for individuals with chronic alcohol use and certain other conditions, such as severe renal impairment, as these factors may increase the overall safety risk based on official labeling.

Overdose and Emergency Response

Overdose and when to seek help

The regulatory profile for Corgic (Acetaminophen) overdose is defined by the risk of severe, progressive liver toxicity, which necessitates immediate emergency action.

Overdose Scope

Domain Official Regulatory Description
Documented Presentations Early symptoms are often non-specific, including nausea, vomiting, diaphoresis (sweating), paleness, and abdominal pain. Clinical signs of severe injury, such as jaundice, may be delayed.
Life-Threatening Outcomes The primary severe outcome is acute hepatic failure (hepatotoxicity) and hepatic necrosis, which can lead to the need for liver transplantation or death. Renal failure is also documented as a potential complication.
Immediate Action Required Regulators mandate that medical attention must be sought immediately or Poison Control contacted right away, even if the patient appears asymptomatic. This action is critical because irreversible liver damage can occur with a delayed onset.
Antidote and Management The prompt administration of N-acetylcysteine is the designated antidote, indicated to prevent or lessen the extent of hepatic injury. Management involves required hospital monitoring and serial assessment of hepatic and renal function.

Population Notes

Individuals with pre-existing hepatic impairment, chronic malnutrition, or a history of chronic alcohol use are explicitly noted in regulatory documents as having an increased susceptibility to severe overdose manifestations.

Therapeutic Uses of Corgic

The medication Corgic is commonly used to provide supportive therapeutic benefit by addressing symptoms related to physical discomfort and systemic imbalance. It is relevant for the management of mild to moderate pain and the easing of fever.

Corgic may be part of symptomatic management across various conditions, including headache, general muscular aches, backache, toothache, and menstrual cramps. It is also relevant when groups of symptoms appear suddenly, such as during common cold or flu episodes, where it assists with managing the distressing manifestations of fever and systemic body aches. This support is relevant when symptoms that interfere with daily functioning become more noticeable.

“It is relevant for easing symptoms and contributes to general well-being during periods of heightened physical distress.”

In clinical settings, Corgic is considered relevant in conditions involving recurrent or episodic manifestations, such as minor joint discomfort associated with osteoarthritis. It is applied in scenarios where additional management of discomfort is required, helping to ease the overall symptom load alongside other treatments.


Quick Fact: Relevant for Acute Symptom Management Corgic may be part of symptomatic management for episodic manifestations of pain and fever.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Corgic — Official Regulatory Information

Corgic (carvedilol) is strictly contraindicated in specific patient populations due to the risk of serious health consequences. Use is generally appropriate for adults in the approved indications who do not have these conditions.


Contraindicated Populations Specific Condition-Based Restrictions
Bronchial asthma or related bronchospastic conditions. Patients with non-allergic bronchospasm (e.g., chronic bronchitis) should generally avoid use, or use with caution at the lowest effective dose.
Second- or third-degree AV block (heart block). Use in severe hepatic (liver) impairment is contraindicated.
Sick sinus syndrome or severe bradycardia (unless a permanent pacemaker is in place). Caution and monitoring are required for patients with renal function deterioration.
Cardiogenic shock or decompensated heart failure requiring IV inotropic therapy. Pregnancy use is only allowed if the potential benefit justifies the potential risk to the fetus. Caution is advised for nursing mothers.
History of serious hypersensitivity reaction (e.g., anaphylaxis, Stevens-Johnson syndrome) to carvedilol or any component. The safety and effectiveness of Corgic have not been established in pediatric populations.

This medication must not be used in patients with the above-listed cardiovascular, respiratory, or severe organ conditions, as officially defined in regulatory labeling. Special consideration and monitoring, including dosage adjustment or discontinuation, are required for individuals with specific conditions like non-allergic bronchospasm, diabetes, or renal function decline.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction-Related Restrictions

Co-administration of Corgic (Acetaminophen) with any other product containing Acetaminophen (prescription or nonprescription) is formally prohibited. This regulatory restriction exists because exceeding the maximum total daily dosage, often unintentionally, significantly increases the risk of severe liver damage, including acute liver failure.

Pharmacokinetic and Pharmacodynamic Interactions

The official interaction profile highlights specific changes in drug exposure and effects when Corgic is combined with certain agents:

  • Anticoagulants: Chronic or high-dose oral use may cause a pharmacodynamic enhancement of the hypoprothrombinemic effect of Warfarin and other Coumarin derivatives, resulting in an officially documented increase in the International Normalized Ratio (INR).
  • Metabolic Alteration: Medicines such as Isoniazid and Rifampin are documented to alter Acetaminophen's metabolism, which may accelerate the production of hepatotoxic metabolites.
  • Absorption Reducers: The absorption of Corgic may be reduced when co-administered with Cholestyramine. This reduction in systemic exposure requires mandatory administration spacing of at least one hour before or four to six hours after the sequestrant.
  • Exenatide: A required timing separation of at least one hour before or four hours after Exenatide injection is documented to mitigate reduced Corgic exposure.

Population-Specific Interaction Notes

The risk of severe liver damage is officially documented as increased with the concurrent chronic use of three or more alcoholic drinks every day. Patients with underlying severe hepatic impairment are also identified in official labeling as a population at significantly increased risk of toxicity from Corgic use.

Mechanism of Action

Central Prostaglandin Synthesis Modulation

Corgic modulates prostaglandin (PG) synthesis pathways primarily within the Central Nervous System (CNS). It acts as a weak inhibitor of cyclooxygenase ( COX) enzymes, particularly under conditions of low hydroperoxide levels, affecting both COX-1 and COX-2 dependent processes. This engagement with PG production modifies the early molecular steps that shape systemic thermoregulatory and nociceptive outcomes.

Descending Serotonergic Pathway Activation

The drug initiates effects by influencing descending serotonergic pathways that originate in the brain and project to the spinal cord. This is a critical mechanistic cascade that influences neural signaling mechanisms that regulate afferent nociceptive processing. By engaging this neural signaling mechanism, Corgic supports a modulated state within targeted central pathways.

Endocannabinoid System Interaction (via Active Metabolite)

Corgic's active metabolite, p-aminophenol, is conjugated to form AM404, which acts as an agonist at cannabinoid receptors ( CB1 receptor). This engagement involves mechanisms that regulate overactive or dysregulated processes in systems where specific mediators like endocannabinoids dominate. The engagement with the endocannabinoid system modifies signaling sequences that influence nociceptive modulation.

Dosage and Administration Information

How Corgic is Used: Administration Guidelines

Corgic (Acetaminophen/Paracetamol) is utilized based on specific parameters concerning route, dosage, frequency, and patient populations. The administration protocol is designed for controlled usage and follows established pharmaceutical standards for the ingredient.

Administration Routes and Dosing

The medicine is available and used via three distinct routes: oral (e.g., tablets, solutions), rectal (via suppositories), and intravenous (IV) infusion, particularly in acute care settings. Standard oral single doses range from 650 mg to 1000 mg for adults weighing 50 kg or more, with the total intake from all sources in a 24-hour period constrained to a maximum daily dose of 4000 mg.

Frequency and Contextual Use

Dosing adherence is structured around a minimum time interval. Administration of Corgic is separated by no less than 4 hours between doses, although a 6-hour interval is commonly used for the highest single doses. Oral forms may be taken independently of food, offering flexibility in timing. Specialized formulations carry specific rules; for instance, extended-release tablets must be swallowed whole and cannot be crushed, chewed, or dissolved. The intravenous solution is required to be infused slowly over a 15-minute period.

Population-Specific Constraints

The dose for children and adolescents weighing less than 50 kg is calculated on a weight-based regimen (e.g., 10 to 15 mg/kg per dose). Furthermore, in cases of severe impairment, such as low renal function, the minimum dosing interval is extended to prevent cumulative exposure.

Recent Clinical Evidence

Research evidence / Overview of studies for Corgic

Evidence for Use in Acute Pain Relief

Research exploring Corgic in the context of short-term pain is primarily built upon a large foundation of Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These studies evaluated Corgic in populations experiencing mild to moderate physical discomfort, such as post-operative pain, dental pain, and headaches. Researchers monitored outcomes related to physical discomfort using patient-reported outcomes describing perceived discomfort on standardized pain scales, as well as the time required for a person to notice a change in their symptoms. The core findings describe patterns observed in the studies related to measurements of pain intensity shortly after administration.

However, follow-up durations were limited, focusing heavily on single doses or brief courses of treatment. Consequently, there is limited information for long-term outcomes or how Corgic's observed pattern of effect might change with continuous use over many weeks for persistent pain conditions.

Evidence for Use in Fever Reduction (Antipyresis)

Corgic was evaluated in studies addressing fever, where research originates from extensive short-term Randomized Controlled Trials (RCTs). Research examined temporary physiological imbalance, specifically monitoring the change in a person's body temperature over a defined time interval. Findings describe patterns observed in the studies regarding measured changes in body temperature, often within the immediate hours after dosing. This evidence is extensive and consistent.

Evidence for Use in Chronic Pain Conditions

Corgic was also evaluated in research involving chronic conditions, most commonly osteoarthritis. Studies explored outcomes reflecting daily functioning and patient-reported discomfort. The findings from systematic reviews and high-level analyses regarding continuous Corgic use in chronic pain conditions were reported as mixed and inconsistent. Many trials described patterns related to pain and function measurements that were considered to be of low clinical relevance. The certainty remains low regarding continuous patterns in chronic pain due to follow-up durations that were limited.

Evidence in Special Populations

Research examining Corgic use in pregnant individuals and its potential relationship with long-term developmental outcomes relies on large-scale Observational Cohort Studies and rigorous Sibling-Controlled Analyses. While initial research described patterns that appeared to suggest an association, more refined analyses reported that these initial associations were no longer observed. Research has not established a causal link between use during pregnancy and developmental issues. This evidence remains limited by the reliance on observational data.

Key Studies & References NICE Guideline: Osteoarthritis: care and management

Frequently Asked Questions (FAQ)

Common questions about Corgic (FAQ)

Q: Is Corgic the same type of medicine as [similar competing drug name]?

A: Corgic contains the active ingredient acetaminophen (paracetamol), which is classified as a non-opioid medicine for pain and fever relief. Official sources indicate that it is chemically distinct from nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, because it has minimal activity against swelling or inflammation.

Q: What is the biggest difference between Corgic and other treatments for [Condition]?

A: Acetaminophen is often considered a first-line treatment for mild to moderate pain and fever because of its widespread use at recommended doses. A major difference when compared to some other pain treatments is its primary focus on changing the way the body processes pain and cooling the body, rather than significantly reducing inflammation.

Q: Why do people say Corgic is a 'last resort' or 'first-line' medication?

A: Globally, acetaminophen is frequently described as a first-line (or initial) therapy for treating fever and many common pain conditions by organizations like the World Health Organization (WHO). This reflects its widespread use as a foundational pain reliever that is supported by health organizations for appropriate use.

Q: How long does the main effect of Corgic typically last in the body?

A: The recommended dosing practices provide an indication of the expected duration of effect. Official administration guidelines describe a time interval between doses that typically ranges from four to six hours, which is related to the medication’s expected duration of effect.

Q: Are there any known interactions between Corgic and common pain relievers?

A: Regulatory documents strictly prohibit taking Corgic with any other product that contains acetaminophen, whether prescription or nonprescription. This restriction is critical to prevent accidentally exceeding the maximum daily dose and increasing the risk of liver damage.

Q: Is it necessary to avoid grapefruit or grapefruit juice while taking Corgic?

A: Official labeling for single-ingredient acetaminophen does not typically contain any specific warnings or restrictions to avoid grapefruit or grapefruit juice.

Q: What non-prescription medicines are known to interact with Corgic?

A: The primary interaction concern involves other non-prescription products that also contain acetaminophen, as combining these can lead to an overdose. Understanding all ingredients is important when considering use of multiple products.

Q: Is Corgic used to treat anything besides the primary condition?

A: While Corgic's general therapeutic purpose is the symptomatic relief of pain and fever, its active ingredient, acetaminophen, is included in hundreds of other over-the-counter products. These often combine it with other ingredients to address symptoms related to colds, flu, and allergies.

Q: What is the mechanism of action of Corgic in simple terms?

A: In plain terms, acetaminophen works primarily in the central nervous system (brain and spinal cord) to help change the way the body experiences or senses pain. It also influences the part of the brain that controls body temperature, which helps to reduce fever.

Q: Is Corgic a controlled substance or habit-forming drug?

A: Acetaminophen is classified as a non-opioid medicine. When taken as officially directed, it is not considered to be habit-forming or a controlled substance.

Q: Can Corgic affect a person's ability to drive or operate machinery?

A: Although specific labels may not always include a driving warning, regulatory bodies advise caution with any medication that has the potential to cause side effects such as dizziness or blurred vision, which could affect concentration or coordination.

Q: Why is it important to read the official label for Corgic?

A: The official product labeling is crucial because it provides essential warnings and regulatory information for safe use. This includes clear guidance on maximum doses, which helps prevent the primary risk of severe liver damage.

Q: What is the pregnancy safety classification for Corgic?

A: Research has not established a causal link between the use of acetaminophen during pregnancy and long-term developmental issues. Official information indicates that use during pregnancy involves weighing the potential benefit against potential risk. Official warnings advise minimizing chronic use during pregnancy.

Q: Is Corgic considered safe to use while breastfeeding?

A: Official information from the NIH and other sources indicates that acetaminophen is generally considered a suitable choice for nursing mothers for pain and fever relief. Only a small amount of the active ingredient passes into the breast milk.

Q: What is the difference between an 'interaction' and a 'contraindication' for Corgic?

A: A contraindication is a very specific condition, such as severe liver disease, that makes the use of the medicine potentially harmful and means it should not be taken. An interaction means caution should be used when two substances (like a drug and alcohol) are combined because they may affect each other.

Q: Do older adults typically have different expectations for Corgic than younger patients?

A: Studies performed to date in the geriatric population have not demonstrated specific problems that would require unique limitations for its general usefulness in this age group.

Q: Is Corgic associated with any long-term health risks mentioned in official sources?

A: The primary safety concern discussed in official sources is the risk of severe liver damage or liver failure. Regulatory warnings emphasize that this risk is strictly associated with exceeding the maximum total daily dosage over a 24-hour period.

Q: Do food choices affect the absorption or effect of Corgic?

A: Oral forms of acetaminophen are generally approved to be taken independently of food. However, certain substances, such as chronic use of alcohol, are officially documented as increasing the safety risk associated with the medicine.

How should Corgic be stored and disposed of?

How to Store and Dispose of Corgic

Official regulatory information defines specific environmental and safety conditions for the storage and disposal of Corgic (Acetaminophen/Paracetamol) to ensure product stability and prevent accidental ingestion.

Storage Conditions

Requirement Details
Temperature Store at controlled room temperature, between 20 C and 25 C (68 F and 77 F).
Protection Keep strictly away from excessive heat, moisture, air, and light; do not store in high-humidity areas like a bathroom cabinet.
Container Must be kept in the original container. Do not use if the inner seal is broken or missing.
Child Safety Store securely out of the reach and sight of children and pets, ideally in a locked or latched cabinet.

Disposal Instructions

Unused or expired Corgic should be disposed of promptly. The preferred method is using an authorized drug take-back program. If this is unavailable, mix the medicine with an unappealing, inedible substance (e.g., dirt, cat litter) in a sealed bag and dispose of it in the household trash. All personal information must be scratched off the label before discarding the empty container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Corgic found in:

A-Z Index: